Resultats globals: 6 registres trobats en 0.01 segons.
Articles, 5 registres trobats
Documents de recerca, 1 registres trobats
Articles 5 registres trobats  
1.
16 p, 1.9 MB Pituitary-Adrenal Axis and Peripheral Immune Cell Profile in Long COVID / Alijotas-Reig, Jaume (Universitat Autònoma de Barcelona. Departament de Medicina) ; Anunciación-Llunell, Ariadna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Esteve-Valverde, Enrique (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Morales-Pérez, Stephanie (Fundació Althaia) ; Rivero-Santana, Sergio (Fundació Althaia) ; Trapé, Jaume (Institut de Recerca i Innovació en Ciències de la Vida i de la Salut a la Catalunya Central) ; González-García, Laura (Institut de Recerca i Innovació en Ciències de la Vida i de la Salut a la Catalunya Central) ; Ruiz, Domingo (Fundació Althaia) ; Marques-Soares, Joana Rita (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Miró-Mur, Francesc (Hospital Universitari Vall d'Hebron. Institut de Recerca)
In Long COVID, dysfunction in the pituitary-adrenal axis and alterations in immune cells and inflammatory status are warned against. We performed a prospective study in a cohort of 42 patients who suffered COVID-19 at least 6 months before attending the Long COVID unit at Althaia Hospital. [...]
2024 - 10.3390/biomedicines12030581
Biomedicines, Vol. 12 (march 2024)  
2.
16 p, 2.5 MB Thrombosis and Hyperinflammation in COVID-19 Acute Phase Are Related to Anti-Phosphatidylserine and Anti-Phosphatidylinositol Antibody Positivity / Alijotas-Reig, Jaume (Universitat Autònoma de Barcelona. Departament de Medicina) ; Anunciación-Llunell, Ariadna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Morales-Pérez, Stephanie (Fundació Althaia) ; Trapé, Jaume (Fundació Althaia) ; Esteve-Valverde, Enrique (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Miró-Mur, Francesc (Hospital Universitari Vall d'Hebron. Institut de Recerca)
Antiphospholipid antibodies (APLA) are strongly associated with thrombosis seen in patients with antiphospholipid syndrome. In COVID-19, thrombosis has been observed as one of the main comorbidities. [...]
2023 - 10.3390/biomedicines11082301
Biomedicines, Vol. 11 (august 2023)  
3.
15 p, 2.5 MB Differences in Antiphospholipid Antibody Profile between Patients with Obstetric and Thrombotic Antiphospholipid Syndrome / Anunciación-Llunell, Ariadna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Muñoz, Cándido (University College of London) ; Roggenbuck, Dirk (GA Generic Assays GmbH (Alemanya)) ; Frasca, Stefano (GA Generic Assays GmbH (Alemanya)) ; Pardos-Gea, Josep (Hospital Universitari Vall d'Hebron) ; Esteve-Valverde, Enrique (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Alijotas-Reig, Jaume (Universitat Autònoma de Barcelona. Departament de Medicina) ; Miró-Mur, Francesc (Hospital Universitari Vall d'Hebron. Institut de Recerca)
Antiphospholipid syndrome (APS) is a systemic autoimmune condition characterised by the presence of antiphospholipid antibodies (aPL) associated with vascular thrombosis and/or pregnancy complications. [...]
2022 - 10.3390/ijms232112819
International journal of molecular sciences, Vol. 23 (october 2022)  
4.
26 p, 855.4 KB Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome : A Comprehensive Review / Alijotas-Reig, Jaume (Universitat Autònoma de Barcelona. Departament de Medicina) ; Esteve-Valverde, Enrique (Althaia Xarxa Assistencial (Manresa)) ; Anunciación-Llunell, Ariadna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Marques-Soares, Joana (Hospital Universitari Vall d'Hebron) ; Pardos-Gea, Josep (Hospital Universitari Vall d'Hebron) ; Miró-Mur, Francesc (Hospital Universitari Vall d'Hebron. Institut de Recerca)
Antiphospholipid syndrome is an autoimmune disorder characterized by vascular thrombosis and/or pregnancy morbidity associated with persistent antiphospholipid antibody positivity. Cases fulfilling the Sydney criteria for obstetric morbidity with no previous thrombosis are known as obstetric antiphospholipid syndrome (OAPS). [...]
2022 - 10.3390/jcm11030675
Journal of clinical medicine, Vol. 11 Núm. 3 (january 2022)  
5.
7 p, 556.8 KB Obstetrical outcome and treatments in seronegative primary APS : data from European retrospective study / Abisror, Noemie (Sorbonne Université) ; Nguyen, Yann (Paris University) ; Marozio, Luca (University of Torino) ; Esteve Valverde, Enrique (Althaia Network Health (Manresa)) ; Udry, Sebastian (Acute Hospital "Dr Carlos G Durand") ; Pleguezuelo, Daniel Enrique (Instituto de Investigación Sanitaria Hospital 12 de Octubre (i+12)) ; Billoir, Paul (Rouen University Hospital (França)) ; Mayer-Pickel, Karoline (Medical University of Graz) ; Urbanski, Geoffrey (CHU d'Angers) ; Zigon, Polona (University Medical Centre Ljubljana) ; De Moreuil, Claire (Université Bretagne Loire) ; Hoxha, Ariela (University of Padua) ; Bezanahary, Holy (University Hospital of Limoges) ; Carbillon, Lionel (Sorbonne University) ; Kayem, Gilles (Sorbonne Université) ; Bornes, Marie (Tenon Hospital) ; Yelnik, Cecile (Université de Lille) ; Johanet, Cathererine (Hôpital Saint Antoine) ; Nicaise-Roland, Pascale (Bichat Hospital) ; Lambert, Marc (Université de Lille) ; Salle, Valéry (University Hospital of Amiens) ; Latino, Omar Jose (Acute Hospital "Dr Carlos G Durand") ; Hachulla, Eric (Université de Lille) ; Benedetto, Chiara (University of Torino) ; Bourrienne, Marie Charlotte (Hôpital Bichat) ; Benhamou, Ygal (Rouen University Hospital (França)) ; Alijotas-Reig, Jaume (Universitat Autònoma de Barcelona. Departament de Medicina) ; Fain, Olivier (Sorbonne Université) ; Mekinian, Arsène (Sorbonne Université)
To compare characteristics, pregnancies and treatments during pregnancies of seronegative and seropositive antiphospholipid syndrome (APS), to analyse factors associated with obstetrical outcome. Inclusion criteria were: (1) thrombotic and/or obstetrical APS (Sydney criteria); (2) absence of conventional antiphospholipid antibodies (APL); (3) at least one persistent non-conventional APL among IgA anticardiolipin antibodies, IgA anti-B2GPI, anti-vimentin G/M, anti-annexin V G/M, anti-phosphatidylethanolamine G/M and anti-phosphatidylserine/prothrombin G/M antibodies. [...]
2020 - 10.1136/rmdopen-2020-001340
RMD Open, Vol. 6 (august 2020)  

Documents de recerca 1 registres trobats  
1.
142 p, 2.4 MB Características clínicas y de laboratorio de la patología obstétrica relacionada con los anticuerpos antifosfolipídicos / Esteve Valverde, Enrique ; Alijotas-Reig, Jaume, dir.
La síndrome antifosfolipídica (SAF) és una malaltia autoimmune en la qual la presència d'anticossos antifosfolipídics (AAF) condicionen l'aparició de trombosi arterials i / o venoses i / o morbiditat obstètrica. [...]
El síndrome antifosfolipídico (SAF) es una enfermedad autoinmune en la que la presencia de anticuerpos antifosfolipídicos (AAF) condicionan la aparición de trombosis arteriales y/o venosas y/o morbilidad obstétrica. [...]
The antiphospholipid syndrome (APS) is an autoimmune disease in which the presence of antiphospholipid antibodies (aPL) leads to arterial and/or venous thrombosis as well as obstetric morbility. The obstetric variant is known as obstetric antiphospholipid syndrome (OAPS) and stands for the main acquired treatable cause of obstetrical morbility during pregnancy. [...]

2021  

Vegeu també: autors amb noms similars
1 Esteve-Valverde, E.
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.